Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Neurology  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Scleroderma Clinical Trials

A listing of Scleroderma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (6) clinical trials

A clinical trial to evaluate treatments for patients with Systemic sclerosis

The total study duration per patient will be 39 weeks; consisting of a 4-week screening, a 24-week of study treatment period, and a 11-week follow-up with no study drug treatment.


A clinical trial seeking patients for a research study for the treatment of Scleroderma, Systemic sclerosis

What will be asked of you: Completion of 2 health questionnaires Donation of research bloods. This is optional, but encouraged (if possible). We also encourage patients who come for initial visits to return so follow-up data can be collected. Benefits to Patients: The HSS Scleroderma Registry gives patients the opportunity ...

Phase N/A

A clinical trial seeking patients for a research study for the treatment of Systemic sclerosis

GSK2330811 is a humanized monoclonal antibody which is in development for systemic sclerosis (SSc), a rare autoimmune disease with high morbidity and mortality. Currently, there are no approved disease modifying therapies and it is an area of high unmet medical need. GSK2330811 has been shown to bind and neutralize Oncostatin ...


A clinical trial seeking patients for a research study for the treatment of Diffuse Scleroderma, Scleroderma, Systemic sclerosis, dcSSc

This is a multicenter prospective double blind placebo controlled dose escalation safety clinical trial with brentuximab vedotin and stable background immunosuppressive therapy in adult individuals with Diffuse Cutaneous Systemic Sclerosis (dcSSc). Adult male and female participants with dcSSc will be recruited by a collaborative group of clinical sites in the ...


A clinical trial sponsored by Corbus Pharmaceuticals Inc. for a research study for the treatment of Diffuse Scleroderma

This is a Phase 3 multicenter, double-blind, randomized, placebo-controlled study assessing the efficacy and safety of lenabasum for the treatment of diffuse cutaneous systemic sclerosis (SSc). Approximately 354 subjects will be enrolled in this study at about 60 sites in North America, Europe, Australia, and Asia. The planned duration of ...


A Phase 2 clinical study for patients with Scleroderma, Systemic sclerosis

Systemic sclerosis (SSc) is a multisystem autoimmune illness characterized by vasculopathy, immune system activation and fibrosis of the skin and internal organs. SSc affects approximately 240 people per million in the US, but is a disease for which there is no FDA approved medication. Current hypothesis of pathogenesis suggest that ...